Tag Archives: specialty medicines

National Chains Carefully Circle Obamacare

by Tom Norton While US Pharma anxiously watches the initial roll out of Obamacare, there are those entities closely associated with the innovator Rx business that have a very different view on what Obamacare means to their concerns.  These firms are carefully circling the new law, thoughtfully observing its implementation, and, generally, viewing its startup […]
Posted in Guest Blog, healthcare, leadership, Legal, Market Access, Regulatory | Also tagged , , , , , , , , , | Leave a comment

Teva Joins Top 10, “Face” of Big Pharma Changing

Teva’s accession to the exclusive group that is the Pharma Top 10 is further proof, according to IMS Health, that branded pharma needs to renounce its product-protected past and embrace the patient-led, specialty-focused future. As the first non-western, non-innovative-core company to enter pharma’s global Top 10, according to IMS Health research, Teva’s rise to prominence […]
Posted in Global, Strategy | Also tagged , , | 1 Comment
  • Categories

  • Meta